BIOA B (Stockholm: BIOA B) partner Eisai announced today that the Biologics License Application (BLA) for the treatment of early Alzheimer's disease with Leqembi (lecanemab), using a subcutaneous ...
BioArctic AB's (publ) (NASDAQ: BIOA B (Stockholm: BIOA B) partner Eisai announced today that the Biologics License Application (BLA) for the treatment ...
These tear-jerking Super Bowl commercials turned seconds of screen time into national experiences that made millions of ...
Chris Hemsworth and Elsa Pataky have showcased their comedic chops in an ad shown during the Super Bowl LX, which was viewed ...
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts ...
Nevada Gov. Joe Lombardo’s 2025 campaign fundraising has reached $4.3 million, heavily relying on a legal loophole that ...
Study Finds on MSN
A few weeks of this training linked to lower dementia risk over 20 years
Memory and reasoning training showed no protective effect, only speed training + follow-up sessions In A Nutshell Older ...
China granted Priority Review for an at-home Alzheimer’s treatment developed by Biogen and Eisai. ・If approved, the ...
Sustained interest in small molecules, bispecific antibodies, and genomics got the ball rolling in the biotech deals arena in ...
Several prototype aircraft that are intended to bring back commercial supersonic travel have been making big strides in recent years – but it is unknown how well the return of Concorde-like flights ...
Ahaan Panday and Aneet Padda's Saiyaara is a 2025 blockbuster romantic movie that set a standard for Indian cinema. Now, the ...
Alzheimer’s disease (AD) can be devastating for patients and their families and is a significant public health concern for society. Eisai’s commitment to Alzheimer’s drug discovery spans over four ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results